SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023543
Filing Date
2020-05-08
Accepted
2020-05-08 16:01:59
Documents
69
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20200331.htm 10-Q 1564731
2 EX-31.1 elox-ex311_7.htm EX-31.1 8719
3 EX-31.2 elox-ex312_8.htm EX-31.2 9287
4 EX-32.1 elox-ex321_6.htm EX-32.1 6899
5 EX-32.2 elox-ex322_10.htm EX-32.2 6863
  Complete submission text file 0001564590-20-023543.txt   5049474

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT elox-20200331.xml EX-101.INS 918138
7 XBRL TAXONOMY EXTENSION SCHEMA elox-20200331.xsd EX-101.SCH 47019
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20200331_cal.xml EX-101.CAL 51250
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20200331_def.xml EX-101.DEF 81354
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20200331_lab.xml EX-101.LAB 341875
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20200331_pre.xml EX-101.PRE 246399
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 20860446
SIC: 8731 Services-Commercial Physical & Biological Research